AntriaBio, Inc.
|
(Name of Issuer)
|
Common Stock, par value $0.001
|
(Title of Class of Securities)
|
037230109
|
(CUSIP Number)
|
Dr. Sankaram Mantripragada
c/o AntriaBio Delaware, Inc.
999 18th Street, Suite 3000 Denver, C0 80202
(303) 357-4644
|
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
|
January 31, 2013
|
(Date of Event which Requires Filing of this Statement)
|
1.
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
|
||||||||||||
Sankaram Mantripragada
|
|||||||||||||
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
||||||||||||
(a)
|
¨
|
||||||||||||
(b)
|
¨
|
||||||||||||
3.
|
SEC Use
only
|
||||||||||||
4.
|
Source of funds
(See Instructions)
|
OO
|
|||||||||||
5.
|
Check if disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)
|
¨
|
|||||||||||
6.
|
Citizenship or Place of Organization
|
United States
|
|||||||||||
Number of Shares Beneficially Owned by Each Reporting Person With:
|
7.
|
Sole Voting
Power
|
6,527,778 shares of Common Stock
|
||||||||||
8.
|
Shared Voting
Power
|
None
|
|||||||||||
9.
|
Sole Dispositive
Power
|
6,527,778 shares of Common Stock
|
|||||||||||
10.
|
Shared Dispositive
Power
|
None
|
|||||||||||
11
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
6,527,778 shares of Common Stock
|
|||||||||||
12.
|
Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
|
¨
|
|||||||||||
13.
|
Percent of Class Represented by Amount in Row (11)
|
16.1%1
|
|||||||||||
14.
|
Type of Reporting Person (See Instructions)
|
||||||||||||
IN
|
1 | Based on 40,527,778 shares of common stock outstanding on February 6, 2013. The shares of common stock outstanding includes the portion of the common stock options that will vest up to sixty days from the date of this Statement. |
Item 1. |
Security and Issuer.
|
Item 2. |
Identity and Background.
|
Item 3. |
Source and Amount of Funds or Other Consideration.
|
Item 4. |
Purpose of Transaction.
|
1.
|
The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;
|
2.
|
An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;
|
3.
|
A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;
|
4.
|
Any change in the present Board of Directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the Board;
|
5.
|
Any material change in the present capitalization or dividend policy of the Issuer;
|
6.
|
Any other material change in the Issuer’s business or corporate structure including, but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the Investment Company Act of 1940;
|
7.
|
Changes in the Issuer’s charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person;
|
8.
|
Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;
|
9.
|
A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended, or
|
Item 5. |
Interest in Securities of the Issuer.
|
a.
|
As of the date hereof, Dr. Mantripragada beneficially owns an aggregate of 6,527,778 Shares of the Issuer, which includes the exercisable portion of the Common Stock Option and the portion of the Common Stock Option that will vest within 60 days of January 30, 2013. Ownership of 6,527,778 Shares represents 16.1% of such outstanding class of the Issuer’s securities. The percentage calculation is based upon 40,527,778 outstanding Shares as of February 6, 2013. The 40,527,778 Shares includes the portion of Common Stock Option that will vest up to sixty days from January 30, 2013.
|
b.
|
The following table sets forth the number of Shares as to which the respective Reporting Person has (i) the sole power to vote or direct the vote, (ii) shared power to vote or to direct the vote, (iii) sole power to dispose or to direct the disposition, or (iv) shared power to dispose or to direct disposition:
|
Reporting Person
|
Sole Voting Power
|
Shared Voting Power
|
Sole Dispositive Power
|
Shared Dispositive Power
|
Sankaram Mantripragada
|
6,527,778
|
6,527,778
|
c.
|
The information contained in Items 3 and 4 above is hereby incorporated herein by reference in its entirety.
|
d.
|
The Reporting Person does not know of any other person with the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities covered by this Statement.
|
e.
|
Not applicable
|
Item 6. |
Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
|
Item 7. |
Material to Be Filed as Exhibits.
|
SANKARAM MANTRIPRAGADA
|
||
Dated: February 8, 2012
|
By:
|
/s/ Sankaram Mantripragada |
Name:
|
Sankaram Mantripragada
|
|